Publicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (10)

2024

  1. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study

    Gastroenterologia y Hepatologia

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2019

  1. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  2. Rate of adverse events of gastroduodenal snare polypectomy for non-flat polyp is low: A prospective and multicenter study

    World Journal of Gastroenterology, Vol. 23, Núm. 47, pp. 8405-8414

2016

  1. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study

    Gut, Vol. 65, Núm. 11, pp. 1829-1837

  2. Safety and risk factors for difficult endoscopist-directed ERCP sedation in daily practice: A hospital-based case-control study

    Revista Espanola de Enfermedades Digestivas, Vol. 108, Núm. 5, pp. 240-245

2012

  1. Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

    Inflammatory Bowel Diseases, Vol. 18, Núm. 5, pp. 812-817